Lung Cancer Trial, Recruiting NCT07134660 Sponsor: Shanghai Pulmonary Hospital, Shanghai, China Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT07134660
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are scheduled for a planned (non-emergency), single-side lung surgery performed using a small camera and instruments through small cuts in the chest (a type of surgery called VATS)
  • People aged between 18 and 80 years old
  • People whose general health before surgery falls within a low-to-moderate risk category as assessed by an anaesthesiologist (confirm with trial site)

Who may not be able to join:

  • People for whom local numbing medications (local anaesthetics) are not safe to use — for example, due to a skin infection at the injection area, an allergy to these medications, or a blood clotting problem or other bleeding risk
  • People who have unusual or altered feeling or sensation in the chest wall area where surgery is planned
  • People with liver problems or kidney problems, as measured by specific blood test results being outside certain ranges (confirm exact values with trial site)
  • People who are pregnant, breastfeeding, planning to become pregnant during the study period, or people who could become pregnant and are not using a reliable form of contraception
  • People who have been using opioid pain medicines before surgery, have a history of long-term (chronic) pain, or have a history of opioid misuse
  • People who do not wish to give their formal agreement (informed consent) to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Xin Y Lv, PhD, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China

Phone: 8615601680288

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
15 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Pain score area under the curve (AUC) from 25 to 72 hours postoperatively

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov